Related Experiment Video
Updated: Sep 2, 2025

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Clinical Correlates and Outcomes of Methamphetamine-Associated Cardiovascular Diseases in Hospitalized Patients in
Lara Curran1, Gregory Nah1, Gregory M Marcus1
1Department of Medicine Division of Cardiology, University of California San Francisco San Francisco CA.
Insights
Methamphetamine use significantly increases cardiovascular disease (CVD) risk, comparable to alcohol and cocaine. Key risk factors among users include chronic kidney disease, hypertension, and mental health disorders.
Area of Science:
- Cardiology
- Public Health
- Addiction Medicine
Background:
- Methamphetamine misuse affects millions globally, with known links to cardiovascular disease (CVD).
- Risk factors for CVD among methamphetamine users remain understudied.
- Understanding these risks is crucial for targeted prevention and treatment strategies.
Purpose of the Study:
- To investigate the association between methamphetamine use and the development of CVD.
- To identify specific risk factors for CVD in methamphetamine users.
- To compare the CVD risk associated with methamphetamine use to that of other substance use disorders.
Main Methods:
- Analysis of hospitalized patients from the Healthcare Cost and Utilization Project database (2005-2011).
- Inclusion of over 20 million individuals, with a focus on 66,199 methamphetamine users.
- Statistical analysis to determine hazard ratios (HR) for CVD events, including heart failure, pulmonary hypertension, stroke, and myocardial infarction.
Main Results:
- Methamphetamine use was associated with increased risk of heart failure (HR 1.53) and pulmonary hypertension (HR 1.42).
- Male sex, chronic kidney disease (HR 2.38), and hypertension (HR 2.26) were significant risk factors for CVD among users.
- Methamphetamine use showed a 32% increase in CVD risk, similar to alcohol (28%) and cocaine (47%).
Conclusions:
- Methamphetamine use poses a substantial risk for cardiovascular disease, on par with alcohol and cocaine abuse.
- Individuals with co-occurring chronic kidney disease, hypertension, and mental health disorders are particularly vulnerable.
- Clinical interventions should prioritize these high-risk groups for CVD prevention and management.
Abstract:
Background Methamphetamine misuse affects 27 million people worldwide and is associated with cardiovascular disease (CVD); however, risk factors for CVD among users have not been well studied. Methods and Results We studied hospitalized patients in California, captured by the Healthcare Cost and Utilization Project database, between 2005 and 2011. We studied the association between methamphetamine use and CVD (pulmonary hypertension, heart failure, stroke, and myocardial infarction). Among 20 249 026 persons in the Healthcare Cost and Utilization Project, 66 199 used methamphetamines (median follow-up 4.58 years). Those who used were more likely younger (33 years versus 45 years), male (63.3% versus 44.4%), smoked, misused alcohol, and had depression and anxiety compared with nonusers. Methamphetamine use was associated with the development of heart failure (hazard ratio [HR], 1.53 [95% CI, 1.45-1.62]) and pulmonary hypertension (HR, 1.42 [95% CI, 1.26-1.60]). Among users, male sex (HR, 1.73 [95% CI, 1.37-2.18]) was associated with myocardial infarction. Chronic kidney disease (HR, 2.38 [95% CI, 1.74-3.25]) and hypertension (HR, 2.26 [95% CI, 2.03-2.51]) were strong risk factors for CVD among users. When compared with nonuse, methamphetamine use was associated with a 32% significant increase in CVD, alcohol abuse with a 28% increase, and cocaine use with a 47% increase in CVD. Conclusions Methamphetamine use has a similar magnitude of risk of CVD compared with alcohol and cocaine. Prevention and treatment could be focused on those with chronic kidney disease, hypertension, and mental health disorders.
More Related Videos
12:31A Visual Description of the Dissection of the Cerebral Surface Vasculature and Associated Meninges and the Choroid Plexus from Rat Brain
Published on: November 14, 2012
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
Related Concept Videos
Coronary Artery Disease III: Clinical Manifestations
Cardiomyopathy II: Dilated Cardiomyopathy
Hypertension III: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations